| Net loss | 369.58M |
| Depreciation and amortization | 134.46M |
| Asset impairment | 0 |
| Noncash loss on early extinguishment of debt recognized as a reorganization item | |
| Accretion of bond discount | |
| Gain on property disposals | |
| Share-based compensation | 5.4M |
| Deferred income tax benefit | -1.29M |
| Restricted cash and cash equivalents | |
| Trade accounts and other receivables | -2.64M |
| Inventories | 4.55M |
| Prepaid expenses and other current assets | -83K |
| Accounts payable, accrued expenses and other current liabilities | -7.81M |
| Income taxes | 45.22M |
| Deposits | |
| Other operating assets and liabilities | -864K |
| Cash used in operating activities | 531.11M |
| Acquisitions of property, plant and equipment | |
| Purchases of investment securities | |
| Proceeds from sale or maturity of investment securities | |
| Proceeds from property disposals | |
| Cash used in investing activities | -163.12M |
| Proceeds from note payable to JBS USA | |
| Proceeds from revolving line of credit and long-term borrowings | 515.29M |
| Payments on revolving line of credit, long-term borrowings and capital lease obligations | -498.12M |
| Proceeds from sale of common stock | |
| Purchase of remaining interest in subsidiary | |
| Payment of capitalized loan costs | |
| Other financing activities | |
| Cash provided by (used in) financing activities | -721.63M |
| Effect of exchange rate changes on cash and cash equivalents | |
| Decrease in cash and cash equivalents | -353.64M |
| Cash and cash equivalents, beginning of period | 439.64M |
| Cash and cash equivalents, end of period | 85.99M |